Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - CASH FROM OPERATIONS
Cash from Operations AVTX - Avalo Therapeutics, Inc.
-30.7 M
LAST VALUE
34.21%
2 YEAR CAGR
-57.88%
5 YEAR CAGR
-10.32%
10 YEAR CAGR